04/18 Lion Biotechnologies, Inc. [NASDAQ: LBIO]
Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Lion Biotechnologies, Inc. Oklahoma City, OK (April 18, 2017) – On April 14, 2017, a securities class action lawsuit was filed in the United States District Court for the Northern District of California against Lion Biotechnologies, Inc. (NASDAQ: LBIO). The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class […]